首页> 外文OA文献 >Risk of hepatocellular carcinoma and fibrosis evolution in hepatitis C patients with severe fibrosis or cirrhosis treated with direct acting antiviral agents

【2h】

Risk of hepatocellular carcinoma and fibrosis evolution in hepatitis C patients with severe fibrosis or cirrhosis treated with direct acting antiviral agents

机译：用直接作用抗病毒药治疗肝炎患者肝细胞癌患者肝细胞癌和纤维化进化的风险

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
C Hamoir; Y Horsmans; P Stärkel; G Dahlqvist; S Negrin Dastis; N Lanthier;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Prolonged abnormal ALT and AFP following SVR and advanced liver fibrosis were associated with hepatocellular carcinoma development in chronic hepatitis C patients who achieved SVR by IFN-free direct-acting antiviral agents. [J] . Sezaki Hitomi, Kobayashi Masahiro, Suzuki Fumitaka, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：SVR和先进的肝纤维化后延长异常ALT和AFP与慢性丙型肝炎患者的肝细胞癌发育相关，所述慢性丙型肝炎患者通过IFN无代理抗病毒药物获得SVR。
2. Changes in fibrotic markers in chronic hepatitis C patients treated with direct antiviral agents and the enhanced liver fibrosis score as a predictor of hepatocellular carcinoma [J] . Kawaguchi Toshihiro, Ide Tatsuya, Amano Keisuke, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：直接抗病毒治疗慢性丙型肝炎患者纤维化标志物的变化及增强肝纤维化评分作为肝细胞癌预测因子
3. Considerable Reduction of Annual Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients with Advanced Hepatic Fibrosis after Direct Acting Antivirals Therapy: A Prospective Study with 2 Years Follow up [J] . Shiha Gamal, Mikhail Nabiel, Soliman Riham, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2018,第6期

机译：直接代理抗病患者治疗后慢性丙型肝炎患者慢性丙型肝炎患者肝细胞癌年风险的显着降低：两年后的前瞻性研究
4. Investigating the biochemical progression of liver disease through fibrosis, cirrhosis, dysplasia, and hepatocellular carcinoma using Fourier Transform Infrared Spectroscopic imaging [C] . Hari Sreedhar, Mamta Pant, Nemencio R Ronquillo, Biomedical vibrational spectroscopy VI: Advances in research and industry . 2014

机译：使用傅立叶变换红外光谱成像技术研究通过纤维化，肝硬化，异型增生和肝细胞癌引起的肝脏疾病的生化进程
5. Healthcare Resources Utilization, Inpatient Mortality, and Risk Behaviors among Patients Infected with Hepatitis C Virus in the United States in the Era of Direct-Acting Antivirals [D] . Alzahrani, Mohammad Saeed. 2020

机译：在直接作用抗病毒中，美国乙型肝炎病毒感染患者的医疗资源利用率，住院死亡率和风险行为
6. A270 DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CIRRHOSIS FROM CHRONIC HEPATITIS C VIRUS TREATED WITH DIRECT ANTIVIRAL AGENTS: THE VICTORIA EXPERIENCE [O] . R Trasolini, J Rauw, L Bulinckx, 2018

机译：A270直接抗病毒剂治疗的慢性丙型肝炎病毒感染肝硬化患者的肝细胞癌发展：维多利亚经验
7. Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis [O] . Salvatore Petta, Luigi Elio Adinolfi, Anna Ludovica Fracanzani, 2018

机译：通过直接作用抗病毒药物消除丙型肝炎病毒改善了严重肝纤维化患者的颈动脉粥样硬化

Risk of hepatocellular carcinoma and fibrosis evolution in hepatitis C patients with severe fibrosis or cirrhosis treated with direct acting antiviral agents

著录项

引文网络

相似文献

相关主题

期刊订阅